Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000500859 | SCV000597725 | uncertain significance | not specified | 2017-03-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002524322 | SCV003334770 | pathogenic | not provided | 2023-05-22 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 388 of the TUBB2A protein (p.Met388Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with TUBB2A-related conditions (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 437124). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TUBB2A protein function. For these reasons, this variant has been classified as Pathogenic. |
Génétique des Maladies du Développement, |
RCV001788236 | SCV002029254 | likely pathogenic | Complex cortical dysplasia with other brain malformations 5 | no assertion criteria provided | clinical testing |